Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease

被引:100
作者
Caminiti, Silvia Paola [1 ,2 ]
Presotto, Luca [2 ]
Baroncini, Damiano [3 ]
Garibotto, Valentina [4 ]
Moresco, Rosa Maria [5 ,6 ]
Gianolli, Luigi [7 ]
Volonte, Maria Antonietta [3 ]
Antonini, Angelo [8 ,9 ]
Perani, Daniela [1 ,2 ,7 ]
机构
[1] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Div Neurosci, Via Olgettina 58, I-20132 Milan, Italy
[3] Osped San Raffaele, Dept Neurol, Via Olgettina 60, I-20132 Milan, Italy
[4] Univ Geneva, Geneva Univ Hosp, Dept Med Imaging, Geneva, Switzerland
[5] IBFM CNR, Segrate, Italy
[6] Univ Milano Bicocca, Dept Hlth Sci, Tecnomed Fdn, Monza, Italy
[7] Osped San Raffaele, Nucl Med Unit, Via Olgettina 60, I-20132 Milan, Italy
[8] IRCCS Hosp San Camillo, Parkinsons Dis & Movement Disorders Unit, Via Alberoni 70, I-30126 Venice, Italy
[9] Univ Padua, Dept Neurosci DNS, Via Giustiniani 5, I-35128 Padua, Italy
关键词
Parkinson's disease; Positron emission tomography; Dopamine transporter; Axonal damage; Molecular connectivity; VENTRAL TEGMENTAL AREA; POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL CONNECTIVITY; SUBSTANTIA-NIGRA; BRAIN; TRANSPORTER; PET; DISORDERS; PATHOLOGY; NETWORKS;
D O I
10.1016/j.nicl.2017.03.011
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
A progressive loss of dopamine neurons in the substantia nigra (SN) is considered the main feature of idiopathic Parkinson's disease (PD). Recent neuropathological evidence however suggests that the axons of the nigrostriatal dopaminergic system are the earliest target of a-synuclein accumulation in PD, thus the principal site for vulnerability. Whether this applies to in vivo PD, and also to the mesolimbic system has not been investigated yet. We used [C-11]FeCIT PET to measure presynaptic dopamine transporter (DAT) activity in both nigrostriatal and mesolimbic systems, in 36 early PD patients (mean disease duration in months +/- SD 21.8 +/- 10.7) and 14 healthy controls similar for age. We also performed anatomically-driven partial correlation analysis to evaluate possible changes in the connectivity within both the dopamine networks at an early clinical phase. In the nigrostriatal system, we found a severe DAT reduction in the afferents to the dorsal putamen (DPU) (eta(2) = 0.84), whereas the SN was the less affected region (eta(2) = 0.31). DAT activity in the ventral tegmental area (VTA) and the ventral striatum (VST) were also reduced in the patient group, but to a lesser degree (VST eta(2) = 0.71 and VTA eta(2) = 0.31). In the PD patients compared to the controls, there was a marked decrease in dopamine network connectivity between SN and DPU nodes, supporting the significant derangement in the nigrostriatal pathway. These results suggest that neurodegeneration in the dopamine pathways is initially more prominent in the afferent axons and more severe in the nigrostriatal system. Considering PD as a disconnection syndrome starting from the axons, it would justify neuroprotective interventions even if patients have already manifested clinical symptoms.
引用
收藏
页码:734 / 740
页数:7
相关论文
共 54 条
[1]   The vulnerable ventral tegmental area in Parkinson's disease [J].
Alberico, Stephanie L. ;
Cassell, Martin D. ;
Narayanan, Nandakumar S. .
BASAL GANGLIA, 2015, 5 (2-3) :51-55
[2]   Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice [J].
Ba, Fang ;
Martin, W. R. Wayne .
PARKINSONISM & RELATED DISORDERS, 2015, 21 (02) :87-94
[3]   Dorsolateral Prefrontal Cortex Drives Mesolimbic Dopaminergic Regions to Initiate Motivated Behavior [J].
Ballard, Ian C. ;
Murty, Vishnu P. ;
Carter, R. McKell ;
MacInnes, Jeffrey J. ;
Huettel, Scott A. ;
Adcock, R. Alison .
JOURNAL OF NEUROSCIENCE, 2011, 31 (28) :10340-10346
[4]   Stages in the development of Parkinson's disease-related pathology [J].
Braak, H ;
Ghebremedhin, E ;
Rüb, U ;
Bratzke, H ;
Del Tredici, K .
CELL AND TISSUE RESEARCH, 2004, 318 (01) :121-134
[5]  
Calo L, 2016, MOV DISORD
[6]  
Caminiti S. P., 2016, J CEREB BLOOD FLOW M
[7]  
Castrioto A., 2016, Mov Disord
[8]   PET/MRI for Neurologic Applications [J].
Catana, Ciprian ;
Drzezga, Alexander ;
Heiss, Wolf-Dieter ;
Rosen, Bruce R. .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (12) :1916-1925
[9]   PET Studies of D2-Receptor Binding in Striatal and Extrastriatal Brain Regions: Biochemical Support In Vivo for Separate Dopaminergic Systems in Humans [J].
Cervenka, Simon ;
Varrone, Andrea ;
Fransen, Erik ;
Halldin, Christer ;
Farde, Lars .
SYNAPSE, 2010, 64 (06) :478-485
[10]  
Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO